Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome

Grants

Funding Acknowledgements

This work was supported by grant UM1 CA167551 from the National Cancer Institute and through cooperative agreements with the following Colon Cancer Family Registry centres: Australasian Colorectal Cancer Family Registry (U01 CA074778 and U01/U24 CA097735); Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800); Ontario Familial Colorectal Cancer Registry (U01/U24 CA074783); Seattle Colorectal Cancer Family Registry (U01/U24 CA074794); University of Hawaii Colorectal Cancer Family Registry (U01/U24 CA074806); and USC Consortium Colorectal Cancer Family Registry U01/U24 CA074799).Seattle CCFR research was also supported by the Cancer Surveillance System of the Fred Hutchinson Cancer Research Centre, which was funded by control nos. N01-CN-67009 (1996-2003) and N01-PC-35142 (2003-2010) and contract no. HHSN2612013000121 (2010-17) from the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute, with additional support from the Fred Hutchinson Cancer Research Centre.The collection of cancer incidence data for the State of Hawaii used in this study was supported by the Hawaii Department of Health as part of the state-wide cancer reporting programme mandated by: Hawaii Revised Statutes; and the National Cancer Institute's Surveillance, Epidemiology and End Results Program (SEER) under control nos. N01-PC-67001 (1996-2003) and N01-PC-35137 (2003-2010) and contract nos. HHSN26120100037C (2010-2013) and HHSN261201300009I (2010_current) awarded to the University of Hawaii. The ideas and opinions expressed herein are those of the author(s), and endorsement by the State of Hawaii, Department of Health, the National Cancer Institute, SEER Program or their contractors and subcontractors is not intended nor should be inferred.The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the state-wide cancer reporting programme mandated by: California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers forDisease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s), and endorsement by the State of California, Department of Public Health the National Cancer Institute and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred.This work was also supported by Centre for Research Excellence grant APP1042021 and programme grant APP1074383 from the National Health and Medical Research Council (NHMRC), Australia. AKW is an NHMRC Early Career Fellow. MAJ is an NHMRC Senior Research Fellow. JLH is a NHMRC Senior Principal Research Fellow. DDB is a University of Melbourne Research at Melbourne Accelerator Program (R@MAP) Senior Research Fellow.